China Pharma Inc.

AI Score

0

Unlock

0.20
-0.00 (-0.10%)
At close: Jan 15, 2025, 9:34 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02
Revenue 7.01M 8.10M 9.64M 10.87M 10.92M 12.33M 13.21M 15.57M 20.35M 22.13M 32.81M 54.51M 81.17M 74.39M 61.70M 50.97M 33.19M 21.84M 8.66M 23.27K 110.08K 37.49K
Cost of Revenue 7.29M 8.60M 9.29M 8.91M 9.44M 10.36M 10.74M 12.35M 18.89M 19.47M 29.59M 40.43M 52.18M 44.11M 36.05M 25.68M 17.62M 11.75M 4.17M 47.68K n/a n/a
Gross Profit -281.08K -493.92K 349.27K 1.95M 1.48M 1.97M 2.47M 3.22M 1.46M 2.67M 3.22M 14.08M 28.99M 30.28M 25.65M 25.29M 15.57M 10.10M 4.49M -24.41K 110.08K 37.49K
Operating Income -2.75M -3.55M -3.12M -2.46M -3.39M -3.97M -4.50M -4.19M -14.20M -36.55M -14.91M 6.50M 22.03M 24.66M 22.61M 19.73M 12.25M 8.62M 4.24M -117.37K -155.64K -714.83K
Interest Income 6.60K 10.76K 3.04K 5.67K 27.53K 38.52K 64.41K 130.57K 119.92K 69.74K 8.46K 4.94K 7.21K 15.41K 30.70K 45.17K 31.80K 991.00 769.00 n/a n/a n/a
Pretax Income -3.08M -3.97M -3.40M -2.87M -20.70M -10.86M -19.15M -8.87M -15.35M -39.47M -18.95M 5.60M 22.71M 26.10M 22.49M 19.54M 12.66M 8.59M 4.05M -117.37K -180.17K -1.10M
Net Income -3.08M -10.22M -3.94M -3.16M -21.02M -10.75M -19.28M -9.18M -15.41M -26.05M -20.01M 4.62M 19.27M 23.41M 20.23M 17.83M 12.82M 8.59M 3.80M -504.29K -226.37K -1.10M
Selling & General & Admin 2.25M 2.87M 3.15M 4.04M 4.64M 5.77M 6.87M 7.39M 16.34M 36.42M 16.44M 7.28M 7.16M 5.58M 4.85M 5.56M 3.32M 1.47M 247.03K 92.96K 265.72K 752.32K
Research & Development 240.08K 185.86K 318.96K 377.96K 229.64K 172.38K 90.47K 365.97K 961.90K 2.80M 1.68M 438.66K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses -15.76K 93.85K n/a 115.19B 7,576.50B n/a 4,833.80B n/a n/a n/a n/a 1,464.70B -193.59K 505.22K -1.82M 1.85B n/a n/a n/a n/a n/a n/a
Operating Expenses 2.47M 3.15M 3.46M 4.42M 4.87M -12.42M -21.15M -11.37M -15.76M -41.43M -21.83M -8.17M 6.96M 6.09M 3.04M 5.56M 3.32M 1.47M 247.03K 92.96K 265.72K 752.32K
Interest Expense 333.60K 434.62K 542.00K 294.16K 321.72K 451.26K 539.33K 849.56K 1.17M 785.80K 348.70K 308.38K 255.20K 168.26K 154.18K 131.03K 237.40K 145.88K 186.45K 5.59K 5.59K 49.85K
Selling & Marketing Expenses 780.33K 1.07M 1.50M 2.22M 2.35M 3.22M 3.46M 4.04M 4.29M 3.35M 3.28M 3.54M 3.44M 2.54M 2.71M 2.04B n/a n/a n/a n/a 172.76K n/a
Cost & Expenses 9.76M 5.54M 12.76M 13.33M 14.31M -2.07M -10.40M 978.03K 3.12M -21.96M 7.76M 32.26M 59.14M 50.19M 39.08M 31.24M 20.94M 13.22M 4.41M 140.64K 265.72K 752.32K
Income Tax n/a 6.25M 542.00K 294.16K 321.72K 109.99K 122.63K 308.18K 60.44K 77.04K 1.06M 983.92K 3.44M 2.69M 2.26M 1.71M -162.87K -217.96K 252.10K 762.66K 95.25K 678.89K
Shares Outstanding (Basic) 3.38M 5.26M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M
Shares Outstanding (Diluted) 3.38M 5.26M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M 4.61M
EPS (Basic) -0.91 -1.94 -0.85 -0.72 -4.82 -2.47 -4.42 -2.11 -3.54 -5.99 -4.6 1.06 4.40 5.40 4.30 4.40 3.50 2.50 3.40 -0.45 -0.35 -1.95
EPS (Diluted) -0.91 -1.94 -0.85 -0.72 -4.82 -2.47 -4.42 -2.11 -3.54 -5.98 -4.59 1.06 4.40 5.40 4.30 4.40 3.40 2.50 3.40 -0.45 -0.35 -1.95
EBITDA 8.44K -837.69K 230.34K 106.85K -17.45M -7.15M -15.32M -4.95M -10.58M -36.90M -16.99M 7.37M 24.14M 27.77M 24.02M 20.39M 12.67M 9.02M 4.49M 768.15K 386.82K -383.44K
Depreciation & Amortization 2.75M 2.70M 3.09M 2.68M 2.93M 3.26M 3.29M 3.08M -3.60M -1.79M -1.61M -1.46M 1.17M 1.51M 1.40M 719.48K 422.44K 397.00K 250.18K 504.19K 67.27K 83.31K